Intracranial Aneurysm Market Share

North America Market Forecast

North America industry is likely to account for largest revenue share of 29.7% by 2037, The market growth can be attributed to a combination of technological advancements, increasing prevalence of risk factors, and robust healthcare infrastructure. High rates of hypertension, smoking, obesity, and alcohol consumption contribute to the increasing prevalence of intracranial aneurysms in the region.

The U.S. has a rising rate of hypertension, smoking, obesity, and alcohol consumption, which increases the risk of developing aneurysms. According to the United States Department of Health and Human Services, from August 2021 to August 2023, the prevalence of hypertension among people aged 18 and older was 47.7%. Adults aged 18-39 had a prevalence of 23.4%, which increased to 52.5% for ages 40-59 and 71.6% for those aged 60 and older. The country is home to numerous specialized neurology and neurosurgery centers offering state-of-the-art diagnostic and treatment options for intracranial aneurysms.  A well-established emergency care infrastructure ensures prompt treatment of ruptured aneurysms, reducing mortality rates and improving outcomes.

Moreover, comprehensive health insurance policies in the U.S. cover a wide range of diagnostic and treatment options for intracranial aneurysms, reducing financial barriers for patients. Also, the presence of major industry players like Medtronic, Stryker, and Penumbra is driving innovation and ensuring the availability of advanced products.

In Canada, the rising adoption of minimally invasive procedures such as endovascular coiling and flow diverters is a significant growth factor. These treatments are preferred due to shorter recovery times and reduced surgical risks. The country also has a growing patient population with intracranial aneurysms, which drives the demand for diagnosis and treatment options. This is accompanied by heightened awareness of neurological conditions and their management.

APAC Market Analysis

The intracranial aneurysm market of Asia Pacific is poised to register the fastest revenue growth by 2037. The region has seen significant advancements in diagnostic and treatment technologies. Additionally, minimally invasive procedures are gaining traction for their effectiveness and safety. APAC has immense potential for continued development and innovation in treatment methods and healthcare infrastructure improvement.

India is emerging as a hub for medical tourism due to the cost-effectiveness of surgeries. This is driving domestic as well as international patients, thus boosting the intracranial aneurysm market. also, the country’s healthcare spending has been rising steadily, with the government allocating 2.1% of its GDP to health in 2023, reflecting a focus on advanced treatments such as minimally invasive procedures for aneurysms.

In China, the government’s commitment to enhancing healthcare systems, coupled with rising private investments, supports the adoption of innovative aneurysm treatment technologies. The overall healthcare expenditure is projected to grow further fostering intracranial aneurysm market expansion.